Basic Information
Basic information for LINC00221-203-66aa
Peptide Name LINC00221-203-66aa
Genome Position chr14:106490521-106490718[+]
Species Human
Peptide Sequence MTAAFLAVKGTRSVLAYGFCGSQATCLPRFSPLRTGGDESLPSLEFLEPEYTKKPHTKLLKRAPQA
Peptide Length 66
Unique Yes
Grand Average of Hydropathicity -0.2167
Relative Molecular Mass 8356.5
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000270816;LINC00221
Transcript ID/Name ENST00000620337;LINC00221-203
Transcript Length 1586
Coding Ability 0.3499
DNA Sequence Corresponding to Peptide ATGACAGCTGCATTTCTTGCAGTCAAGGGAACTCGGAGTGTTTTAGCTTATGGGTTCTGTGGAAGCCAGGCCACTTGTCTTCCTCGCTTCAGCCCCCTTCGCACAGGAGGTGACGAATCTCTTCCCTCACTGGAGTTCCTGGAGCCAGAGTATACAAAGAAGCCACACACAAAGCTCCTAAAGAGAGCTCCACAGGCC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :